Cargando…
The Clinical Significance of Serum Biomarkers of the Intestinal Barrier in Systemic Sclerosis: A Cross-Sectional Study
Systemic sclerosis (SSc) is an immune-mediated connective tissue disease. Recent studies reported differences in the composition of intestinal microbiota (dysbiosis) in patients with SSc compared to nonsclerodermic subjects. Dysbiosis may disrupt the intestinal barrier, which leads to immunological...
Autores principales: | Stec, Albert, Maciejewska, Magdalena, Zaremba, Michał, Paralusz-Stec, Karolina, Michalska, Milena, Rudnicka, Lidia, Sikora, Mariusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141873/ https://www.ncbi.nlm.nih.gov/pubmed/37109064 http://dx.doi.org/10.3390/jpm13040678 |
Ejemplares similares
-
The Gut Microbial Metabolite Trimethylamine N-Oxide is Linked to Specific Complications of Systemic Sclerosis
por: Stec, Albert, et al.
Publicado: (2023) -
Bacterial Metabolites: A Link between Gut Microbiota and Dermatological Diseases
por: Stec, Albert, et al.
Publicado: (2023) -
Copeptin as a Biomarker of Microcirculation Alterations in Systemic Sclerosis
por: Maciejewska, Magdalena, et al.
Publicado: (2023) -
Hypoxia-Inducible Factor-1α (HIF-1α) as a Biomarker for Changes in Microcirculation in Individuals with Systemic Sclerosis
por: Maciejewska, Magdalena, et al.
Publicado: (2023) -
Intestinal Fatty Acid Binding Protein, a Biomarker of Intestinal Barrier, is Associated with Severity of Psoriasis
por: Sikora, Mariusz, et al.
Publicado: (2019)